MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cam4.71345

Медицинская библиотека · Cancer medicine · 2025

Single-Cell Transcriptomic Analysis Identifies a Novel OLR1+ SLC7A7+ Liver-Enriched Metastatic Subset With Immunometabolic Rewiring in Pancreatic Cancer.

Yang Xuan, Chen Xinyuan, Wang Zixin, Liu Yanfang, Hu Huiting, Wu Qingru, Zhang Hailing, Xiong Yu, Li Xin, Cheng Xiaotao, Ruan Xiaoyu, Gu Yan

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Pancreatic ductal adenocarcinoma (PDAC) is an exceptionally lethal malignancy, with high percents of patients presenting with liver metastases (LM). However, the mechanisms driving liver metastases remain critical bottlenecks requiring urgent exploration.

OBJECTIVE

To identify the key cellular subsets driving PDAC liver metastases, elucidate their interactions with the metastatic microenvironment, and define the underlying mechanisms of liver colonization.

MATERIALS AND

METHODS

Integrated single-cell transcriptomic analysis was performed using scRNA-seq data of PT and LM. The expression of signature genes within the identified cell subset was validated using clinical samples from PDAC PT and LM patients. Furthermore, ligand-receptor network analysis was conducted between the specific tumor cell subset and key immune cells.

RESULTS

We identified a novel liver-enriched metastatic subset (LEMS), a terminally differentiated malignant cell subpopulation characterized by metabolic reprogramming and hyperactivation of immunosuppressive pathways. We further validated the LEMS signature genes, oxidized low-density lipoprotein receptor 1 (OLR1) and solute carrier family 7 member 7 (SLC7A7), as potential diagnostic biomarkers for liver metastases. Importantly, we found that SPP1+ macrophages interacted with LEMS via ligand-receptor networks, thereby driving invasion and immune evasion.

DISCUSSION: We revealed the highly malignant features of LEMS and crosstalk between LEMS and SPP1+ macrophages in liver metastases. However, it is necessary to expand clinical cohorts and in vivo models to comprehensively elucidate the specific mechanistic interactions between LEMS and macrophages.

CONCLUSION

We delineated LEMS as an enriched subset in LM and proposed targeting of LEMS-SPP1+ macrophage interactions as a therapeutic strategy to disrupt metastatic progression.

Для цитирования: Yang Xuan, Chen Xinyuan, Wang Zixin, Liu Yanfang, Hu Huiting, Wu Qingru, Zhang Hailing, Xiong Yu, Li Xin, Cheng Xiaotao, Ruan Xiaoyu, Gu Yan. Single-Cell Transcriptomic Analysis Identifies a Novel OLR1+ SLC7A7+ Liver-Enriched Metastatic Subset With Immunometabolic Rewiring in Pancreatic Cancer.. Cancer medicine. 2025. DOI: 10.1002/cam4.71345.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.